Smarter Technologies just expanded its AI revenue cycle platform into inpatient utilization management. The move signals where the market is heading: AI embedded across the entire order-to-payment workflow, not just at billing.
Smarter Technologies announced the launch of SmarterUtilization, a clinical AI solution designed to bring intelligence directly into inpatient utilization management workflows. The product extends the company's existing platform — which includes SmarterPrebill and SmarterNotes — into one of the most labor-intensive and denial-prone functions in hospital revenue cycle operations.
For RCM leaders, this isn't just a product launch. It's a signal about where the AI-in-RCM market is heading.
Smarter Technologies claims 5:1 ROI on its SmarterPrebill product and serves over 200 healthcare organizations. The company did not disclose SmarterUtilization pricing at launch.
Utilization management sits at the intersection of clinical and financial operations — and it's been a persistent blind spot for most RCM automation efforts. The core problem: UM decisions require real-time clinical judgment about level-of-care determinations, and those decisions directly drive payer authorization outcomes and downstream reimbursement.
SmarterUtilization is designed to address this by connecting clinical documentation data with financial workflow intelligence. Specifically, it claims to:
When paired with SmarterNotes — the company's clinical documentation product — the combined platform promises to handle both the documentation quality and the utilization decision in one environment. That's a meaningful integration point that most standalone UM tools don't offer.
Prior authorization and denial management have absorbed most of the AI investment in RCM over the past three years. Utilization management has been slower to automate — partly because it requires genuine clinical judgment, and partly because the workflow touches multiple stakeholders: physicians, UM nurses, case managers, and payer representatives.
AI-assisted UM is only as good as the payer agreement rate data it's trained on. If SmarterUtilization's payer-specific intelligence is sparse for your top commercial contracts, the AI recommendations will underperform. Ask for payor-specific accuracy validation during any evaluation.
The broader market dynamic driving this launch: Medicare Advantage plans have dramatically increased utilization review scrutiny, with CMS data showing a 56% surge in MA denials over the past two years. Health systems are under pressure to front-load clinical justification before payers can issue denials — which is exactly the problem SmarterUtilization is designed to solve.
Smarter Technologies is moving in the same direction as several other platform players — toward end-to-end revenue cycle intelligence rather than point solutions. The strategic logic is clear: every handoff between a standalone prior auth tool, a CDI platform, a UM solution, and a denial management system is a data gap and a workflow friction point. Vendors that can collapse those handoffs into a single platform have a structural advantage.
The companies to watch in this space:
If you're evaluating SmarterUtilization, the key validation question is EHR integration depth. UM workflows live inside Epic and Cerner — a solution that requires toggling to a separate screen loses most of its efficiency value. Demand a live demo of the integrated workflow, not a slide deck.
SmarterUtilization is a logical extension of what Smarter Technologies has been building, and the UM space is genuinely underserved by AI automation. Whether this product delivers on its claims depends on two things that press releases never answer: payer data coverage depth and EHR integration quality.
For health systems actively struggling with MA utilization denials and UM staff capacity constraints — which is most of them right now — this is worth putting on the evaluation list. For organizations where prior auth automation and CDI are still immature, there's a sequencing argument for getting those right before adding UM to the mix.
The broader signal is clear: AI in RCM is moving upstream, from billing toward clinical decisions. The vendors that win the next five years will be the ones that can operate credibly in both domains.
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.
Subscribe Free →